Pharming Group NV (PHAR) — Long-term Investment Intensity
Pharming Group NV (PHAR) has a Long-term Investment Intensity of 1.7% as of December 2025. Long-term investments of $8.65 Million represent 1.7% of total assets of $499.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Pharming Group NV's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Pharming Group NV Long-term Investment Intensity (2019–2025)
This chart shows how Pharming Group NV's Long-term Investment Intensity has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the intensity stands at 1.7%, reflecting long-term investments of $8.65 Million against total assets of $499.81 Million USD. For the complete balance sheet picture, see how large is Pharming Group NV's balance sheet.
Annual Long-term Investment Intensity for Pharming Group NV (2019–2025)
The table below presents the year-by-year Long-term Investment Intensity for Pharming Group NV from 2019 to 2025, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Pharming Group NV balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 1.7% | $8.65 Million | $499.81 Million | ▲ +0.7 pp |
| 2024 | 1.1% | $4.23 Million | $399.99 Million | ▼ -1.2 pp |
| 2023 | 2.2% | $10.40 Million | $462.85 Million | ▼ 0.0 pp |
| 2022 | 2.3% | $9.73 Million | $425.80 Million | ▲ +0.1 pp |
| 2021 | 2.2% | $8.79 Million | $397.31 Million | ▲ +0.5 pp |
| 2020 | 1.7% | $5.80 Million | $342.55 Million | ▼ -0.5 pp |
| 2019 | 2.2% | $5.51 Million | $255.91 Million | — |